|
|
| | Levofloxacin-13C-D3/ Ofloxacin-13C-D3 Basic information |
| Product Name: | Levofloxacin-13C-D3/ Ofloxacin-13C-D3 | | Synonyms: | Levofloxacin-13C-D3/ Ofloxacin-13C-D3;(?)-Ofloxacin-(N-methyl-13C,d3);[13C,2H3]-Levofloxacin;Levofloxacin-(N-methyl-13C,d3);Levofloxacin-13C-D3Q: What is
Levofloxacin-13C-D3 Q: What is the CAS Number of
Levofloxacin-13C-D3 Q: What is the storage condition of
Levofloxacin-13C-D3 Q: What are the applications of
Levofloxacin-13C-D3;13C3,2H3]-Levofloxacin | | CAS: | 1261398-33-7 | | MF: | C18H17D3FN3O4 | | MW: | 365.394988534 | | EINECS: | | | Product Categories: | | | Mol File: | 1261398-33-7.mol |  |
| | Levofloxacin-13C-D3/ Ofloxacin-13C-D3 Chemical Properties |
| storage temp. | 2-8°C | | form | Solid | | color | White to off-white |
| | Levofloxacin-13C-D3/ Ofloxacin-13C-D3 Usage And Synthesis |
| Uses | Levofloxacin-13C,d3 is the 13C- and deuterium labeled Levofloxacin. | | References | [1] Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223. DOI:10.1080/02688697.2018.1500521
[2] Siva, R., et al., Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial. Int J Chron Obstruct Pulmon Dis, 2014. 9: p. 179-86. DOI:10.2147/COPD.S55419
[3] Pradeep, A.R., et al., Clinical and microbiological effects of levofloxacin in the treatment of chronic periodontitis: a randomized, placebo-controlled clinical trial. J Investig Clin Dent, 2014. DOI:10.1111/jicd.12091
[4] Lee, B.T., et al., Efficacy of Levofloxacin in the Treatment of BK Viremia: A Multicenter, Double-Blinded, Randomized, Placebo-Controlled Trial. Clin J Am Soc Nephrol, 2014. DOI:10.2215/CJN.04230413 |
| | Levofloxacin-13C-D3/ Ofloxacin-13C-D3 Preparation Products And Raw materials |
|